COMMUNIQUÉS West-GlobeNewswire

-
NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025
24/04/2025 - 22:15 -
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025
24/04/2025 - 22:15 -
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
24/04/2025 - 22:30 -
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
24/04/2025 - 23:00 -
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
24/04/2025 - 23:00 -
Best Kratom for Energy: Top Strains Recommended by Happy Go Leafy
24/04/2025 - 19:00 -
Clariane I Chiffre d’affaires au 31 mars 2025
24/04/2025 - 19:40 -
Clariane I 2025 first-quarter revenue
24/04/2025 - 19:40 -
Imprivata Names Joel Burleson-Davis as Chief Technology Officer
24/04/2025 - 19:40 -
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
24/04/2025 - 20:00 -
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
24/04/2025 - 20:07 -
May is Brain Cancer Awareness Month: Illuminate the Fight Against One of the Most Lethal Cancers
24/04/2025 - 20:30 -
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
24/04/2025 - 20:49 -
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
24/04/2025 - 15:10 -
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
24/04/2025 - 15:22 -
EY US unveils Richard Hall of USOSM as an Entrepreneur Of The Year® 2025 Southwest Award finalist
24/04/2025 - 15:50 -
Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research
24/04/2025 - 16:00 -
Koelis Announces Partnership with Bot Image™ at AUA 2025
24/04/2025 - 16:12 -
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
24/04/2025 - 16:59
Pages